A seminar called "Flair Nasal Strips: The Clinically Proven Alternative to Lasix" will be held at Keeneland April 9.
With Breeders' Cup at least slowing implementation of its race-day Salix prohibition, the Kentucky Horse Racing Commission could revisit its plans to ban use of the diuretic on race day.
The regulators of eight states in the Northeast region have committed to a uniform medication and drug testing program in a move supporters believe is a step toward uniform regulation of medication and drug testing.
Just days before the Breeders' Cup board of directors conducted a vote on Salix use at its world championships, prominent owners Gary and Mary West threatened litigation against the organization.
Oliver Tait, Darley's chief operating officer, has resigned from the board of the Breeders' Cup following a board decision not to implement a ban on race-day medication for all championship races this year.
The New York Racing Association said Feb. 27 it is considering changes in racing surfaces and is examining internal procedures it uses for rule violations.
Breeders' Cup will not expand its prohibition of furosemide to additional championship races this year but opted to continue last year's policy of banning the diuretic in juvenile races and allowing it in all others.
The National Horsemen's Benevolent and Protective Association Medication Committee voted Feb. 23 to endorse the use of race-day furosemide, also called Salix or Lasix, at this year's Breeders' Cup World Championships.
The Breeders' Cup Board discussed the scheduled prohibition of race-day furosemide at this year's Breeders' Cup World Championships during a Feb. 22 meeting at Gulfstream Park, but took no action.
Horsemen expect members of Congress to make another attempt at winning support for legislation that would regulate medication use in racehorses by banning all race-day administration.
The Maryland Racing Commission voted Feb. 19 to adopt a uniform equine medication, penalty, and testing program proposed for Thoroughbred and Standardbred racetracks throughout the Mid-Atlantic region.
Members passed a resolution supporting The Jockey Club's Reformed Racing Medication Rules including a two-category medication system, progressive points-style penalties, and reciprocity among jurisdictions.
A group of scientists met with representatives of the Thoroughbred Owners of California Jan. 18 to discuss exercise-induced pulmonary hemorrhaging and later issued a joint statement supporting use of furosemide.
Legislation calling for a ban on performance-enhancing drugs in horse racing has been sent to the New York Senate Racing, Gaming, and Wagering Committee.
Mary Simon won her second Eclipse Award for an article examining the history and current state of the race-day use of furosemide (Salix).
Members of the Kentucky Horse Racing Commission staff outlined changes that have been put in place to prevent future mistakes in the administration of race-day Salix at the state's tracks.
Kentucky horsemen are losing patience with a new policy that requires regulatory veterinarians to administer furosemide on race day after mistakes have led to horses being scratched on consectutive race days at Churchill.
Trainers Todd Pletcher and Mark Casse took issue with the Breeders' Cup decision banning the anti-bleeding medication furosemide in this year's five juvenile races during the World Thoroughbred Championships.
Todd Pletcher, who has three top-class juveniles, discusses the ban on Lasix.
Live racing from Santa Anita Park will be available to viewers nationwide on TVG during the track's upcoming winter meet, the California Horse Racing Board learned Oct. 18.
Handicappers must factor in Lasix ban on two-year-old races. read blog
Frustrated with a Breeders' Cup decision to require starters in its five juvenile races at this year's World Championships to race without Salix, owner Mike Repole will not send any horses to this year's event.
The use of racehorse medications and importance of owner education were among the topics discussed among trainers Kellyn Gorder, Tom Proctor, and Phil Sims at the Welfare and Safety of the Racehorse Summit at Keeneland.
At its annual conference, IFHA chairman Louis Romanet has applauded the continued efforts of The Jockey Club to prohibit race-day medication in U.S. racing.
A Kentucky state veterinarian accidentally administered furosemide to a racehorse at Keeneland Oct. 5, the first day a new state rule was enacted that requires the medication to be administered by KHRC vets.
Nearly two months have passed since a coalition of more than 60 owners launched an experiment into Salix-free racing, pledging to run their 2-year-olds without the controversial anti-bleeder medication read blog
The West Virginia Racing Commission heard the pros and cons of race-day furosemide use Sept. 17 and pledged to examine the steps necessary to implement mandatory administration of the anti-bleeding drug by third-party vets.
The Kentucky HBPA said Aug. 31 it is "frustrated and extremely disappointed" with the decision by Kentucky Gov. Steve Beshear to override a vote by a legislative committee that found new equine medical rules deficient.
Kentucky Gov. Steve Beshear Aug. 30 said regulations designed to reform some aspects of the state's equine medication policy will be implemented despite action by a legislative committee that found them deficient.
Two national organizations said Aug. 28 they find it "troubling" factions in Kentucky horse racing are opposing medication regulations proposed by the Kentucky Horse Racing Commission but shot down by a legislative committee.
The California Horse Racing Board's Medication and Track Safety Committee has endorsed proposed changes in race-day administration of furosemide.
The West Virginia Racing Commission has officially scheduled a meeting for Sept. 17 to take comments from industry representatives on the use of furosemide, also known as Salix or Lasix, on race day.
A Kentucky legislative subcommittee, in a surprise vote, found regulations governing equine medication "deficient" Aug. 27, just one week before they are scheduled to take effect.
Furosemide will be the only medication permitted on race day in Kentucky effective Sept. 4, and the drug will be administered by regulatory veterinarians only under new Kentucky Horse Racing Commission rules.
In a change designed to win support of its Reformed Racing Medication Rules, The Jockey Club has added a provision governing regulatory administration of furosemide on race day.
There may be plenty of data out there on trainer performance, but for owners, selecting a conditioner involves much more than numbers, according to an owner and trainer that have worked together for about 15 years.
The West Virginia Racing Commission in late summer or early fall plans to hold a fact-finding meeting on use of furosemide on race day, officials said Aug. 4.
- By Tom LaMarra
The majority of National Horsemen's Benevolent and Protective Association affiliates have adopted resolutions calling for continued regulated use of furosemide on race day.
While many of racing's major issues were discussed at the July 25 meeting of the board of directors of the Association of Racing Commissioners International, the agenda called for few decisions to be made.
Hollywood Casino at Penn National Race Course is the first of three Pennsylvania Thoroughbred tracks to require administration of race-day furosemide by third-party veterinarians.
The Association of Racing Commissioners International is reassessing its policy supporting race-day administration of furosemide, but also indicated much needs to be done before any change is made.
During a June 29 meeting that showed the battle over race-day furosemide is escalating, supporters ripped their opponents and vowed to take their case -- that the medication is good for the racehorse -- to the public.
Did you miss the live show? Listen now to the archived, on demand, version. Listen Now!
- By Tom LaMarra
Regulators around the country are examining the Kentucky Horse Racing Commission's move to phase out race-day furosemide in graded and listed stakes beginning in 2014, but there doesn't appear to be a rush to follow suit.
The controversial subject of furosemide, the anti-bleeder medication widely used in North American racing, will be the subject of the next "Talkin' Horses with The Blood-Horse" live podcast at 2 p.m. EDT, Tuesday, June 26.
- By Tom LaMarra
The Thoroughbred Racing Associations has endorsed a policy for medication reform that has been supported by many industry stakeholders but so far acted upon piecemeal in various jurisdictions.
Some foreign racing organizations issued statements June 14 backing action by the Kentucky Horse Racing Commission to phase out use of race-day furosemide in graded and listed stakes over three years beginning Jan. 1, 2014.
The Kentucky Horse Racing Commission, by a 7-5 vote with one abstention June 13, approved an administrative regulation that would ban the use of furosemide on race day in graded and listed stakes over a three-year period.
In a development that figures to play out in other racing states, two New York senators said June 12 the anti-bleeding medication furosemide should not be banned on race day.
In advance of an expected vote by the Kentucky Horse Racing Commission June 13, the American Graded Stakes Committee reaffirmed its desire to ban all race-day medication in graded stakes for 2-year-olds.
Most Popular Stories
- Minding Overcomes Trouble for Nassau Win
- Seeking the Gold Dies at 31
- China Group to Build Caribbean Resort, Track
- Little Mike Retired to Old Friends
- American Cleopatra Entered at Del Mar
- Borell Arraignment Set for Aug. 1
- Full Field Possible for West Virginia Derby
- Champion Tepin Will Bypass Fourstardave
- Connect Leads 1-2 Finish for Brown in Curlin
- Nyquist, Exaggerator Renew Rivalry in Haskell